2013 ACR/ARHP Annual Meeting Archives - Page 145 of 193

Abstract Number: 1069

Racial Differences In Systemic Lupus Erythematosus Patients’ Treatment Preferences: A Two-Site Study
Abstract Number: 1996

Racial/Ethnicity Differences In Health-Related Quality Of Life (HRQOL), Functional Ability and Health Care Utilization In Gout Patients
Abstract Number: 2469

Radiographic Sacroiliitis Progression In An Early Spondyloarthritis Cohort
Abstract Number: 2804

Radiological Outcome Of Joints With MRI Detected Subclinical Inflammation In Early Arthritis Patients
Abstract Number: 143

Rapid Infrared Microscopy (IRMS) For Differential Diagnosis Of Fibromyalgia and Other Central Sensitivity Syndromes
Abstract Number: 2535

Rare Autoantibodies To Cellular Antigens In Systemic Lupus Erythematosous
Abstract Number: 745

Rate Of Infection and Development Of Malignancy In Patients With ANCA-Associated Vasculitis Treated With Rituximab: A Meta-Analysis From Randomized Trials
Abstract Number: 282

Rates Of Flare-Free Survival In Juvenile Idiopathic Arthritis When Tapering Individual Components Of Tumor Necrosis Factor Inhibitor and Methotrexate Combination Therapy
Abstract Number: 1047

Rates Of Hospitalized Infections In Rheumatoid Arthritis Patients From 5 Rheumatoid Arthritis Registries Across The World
Abstract Number: 782

Rates Of Malignancies In Patients From 5 Rheumatoid Arthritis Registries Across The World
Abstract Number: 1458

Rates Of Switching and Healthcare Costs Associated With Switching Biologic Disease-Modifying Antirheumatic Drugs In a Commercial Population: Evidence From Real-World Observational Studies
Abstract Number: 504

Raynaud’s Phenomenon and African American Race Are Independently Associated With Non-Hodgkin’s Lymphoma In Sjogrens Syndrome Patients: Findings From a United States National Study
Abstract Number: 1791

Reaching The Target Of Low Disease Activity At 6 Months Predicts Better Long-Term Functional Outcome In Patients With Early Rheumatoid Arthritis
Abstract Number: 1030

Readability of Participant Information and Consent Forms for Rheumatology Clinical Trial Participants
Abstract Number: 1718

Reading Of The Sacroiliac Joints On Plain Radiographs: Agreement Between Clinical Practice and Trained Central Reading Of The DESIR-Cohort
Abstract Number: 2852

Real-Life Assessment Of The Validity Of Patient Global Impression Of Change In Fibromyalgia
Abstract Number: 473

Real-World Effectiveness and Safety Of Infliximab In The Treatment Of Rheumatoid Arthritis Over 5 Years: The Canadian Experience
Abstract Number: 1554

Real-World Effectiveness Of Infliximab In The Treatment Of Psoriatic Arthritis Over 12 Months: The Canadian Experience
Abstract Number: 1468

Reasons For Discontinuation Of Biologic Agents In Rheumatoid Arthritis Patients
Abstract Number: 849

Reasons For Failure To Obtain Influenza and Pneumococcal Vaccines Among Immunosuppressed Individuals With Systemic Lupus Erythematosus
Abstract Number: 794

Recent Trends In Medication Usage for the Treatment of Juvenile Idiopathic Arthritis and the Influence of TNF Inhibitors
Abstract Number: 2647

Recombinant Monoclonal Antibodies Derived From Single CD19+ Synovial B Cells Of RA Patients With Tertiary Lymphoid Structures Display a Strong Immunoreactivity Towards Citrullinated Histones
Abstract Number: 2579

Recommendations For Screening and Detection Of Connective-Tissue Disease Associated Pulmonary Arterial Hypertension
Abstract Number: 838

Recommendations for the Classification and Diagnosis of Fibromyalgia Syndrome Provided By Independently Developed Evidence-Based Interdisciplinary Guidelines Spanning Three Continents
Abstract Number: 2127

Recurrences Of Hallux Valgus Deformity After Implant Surgery For Greater Toe In Rheumatoid Arthritis
Abstract Number: 2751

Recurrent Pericarditis In Children and Adolescents: Etiology, Presentation, Therapies, and Outcomes In a Multicenter Retrospective Cohort Of 100 Patients
Abstract Number: 964

Redesign Of a Rheumatology Curriculum For Internal Medicine Residents: Results Of Needs Assessment Survey
Abstract Number: 923

Redox Dependent Conformational Changes Of The Autoantigen La Are Responsible For Its Shuttling, Translocation and a Pathophysiological Role Of Anti-La Autoantibodies
Abstract Number: 2398

Redox Mediated Angiogenesis In The Hypoxic Joint Of Inflammatory Arthritis
Abstract Number: 2681

Reduced Fertility In Women With Rheumatoid Arthritis: Influence Of Disease Activity and Medication Use
Abstract Number: 2602

Reduced Frequencies Of Circulating CD8 T Cells In Early Diffuse Cutaneous Systemic Sclerosis Is Associated With Worse Skin Scores
Abstract Number: 867

Reduced Hip Cortical Porosity Upon Denosumab Treatment: A Likely Mechanism Contributing To The Reduction Of Hip Fracture Risk In Women With Osteoporosis
Abstract Number: 1401

Reduced Oral Glucose Tolerance Is Associated With a Lower Risk Of Rheumatoid Arthritis
Abstract Number: 633

Reduced PD-1 Signaling Promotes Suppressive Function Of CD4⁺ Regulatory T Cells In Patients With Systemic Lupus Erythematosus
Abstract Number: 462

Reduced Response To Biologic Treatments in Rheumatoid Arthritis Patients Affected By Arterial Hypertension
Abstract Number: 2315

Reducing The Need For Total Knee Arthroplasty: The Experience Of a Multidisciplinary Osteoarthritis Clinic
Abstract Number: 939

Reduction Of Circulating Blood Neutrophils In Mice By Anti-IL-6R Alpha Monoclonal Antibody is Not Due To Apoptosis Or Blockade Of Neutrophil Differentiation
Abstract Number: 1520

Reduction Of Disease Burden On Workplace and Household Productivity In Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis, Over 48 Weeks Of Treatment With Certolizumab Pegol
Abstract Number: 326

Reduction Of Disease Burden On Workplace and Household Productivity In Psoriatic Arthritis Over 48 Weeks Of Treatment With Certolizumab Pegol
Abstract Number: 1057

Regional Variations In Rheumatoid Arthritis Treatment and Health Outcomes Across The United States
Abstract Number: 1542

Regular Exercise Is Associated With Better Functional Outcomes In Ankylosing Spondylitis
Abstract Number: 2725

Regulation Of Aberrant CD4 T Cell Activation By Suppressor Of Cytokine Signaling-1 (SOCS1) Mimetic Peptide, Has Relevance To Human Systemic Lupus Erythematosus
Abstract Number: 1145

Regulation Of Plasmacytoid Dendritic Cells By Prostaglandin E2
Abstract Number: 918

Regulatory B Cells Suppress Skin Inflammation in a Murine Model of Psoriasis
Abstract Number: 1402

Regulatory B10 Cells Are Decreased In Patients With Rheumatoid Arthritis and Inversely Correlated With Disease Activity
Abstract Number: 132

Relation Of Age With Symptom Severity and Quality Of Life In Patients With Fibromyalgia
Abstract Number: 615

Relationship Between 25-Hydroxyvitamin D [25(OH)D] and Risk For Cardiovascular Events In Systemic Lupus Erythematosus Over 11 Years In An Inception Cohort
Abstract Number: 2838

Relationship Between Active Inflammatory Lesions In The Spine and Sacroiliac Joints and Development Of Fatty Lesions On Whole-Body MRI In Patients With Early Axial Spondyloarthritis- Long-Term Data Of The Esther Trial
Abstract Number: 1100

Relationship Between Body Mass Index, Fat Mass and Muscle Mass Withmusculoskeletal Pain In Community Residents
Abstract Number: 2475

Relationship Between Extra-Articular Manifestations and Disease Activity In Patients Diagnosed With New-Onset Spondyloarthropathy In a Cohort In Spain
Abstract Number: 744

Relationship Between Infectious Side Effects and Immunoglobulin Levels In The Maintenance Rituximab Vs Azathioprine For ANCA-Associated Vasculitides Trial
Abstract Number: 2330

Relationship Between Lymphocyte Count and Risk Of Infection In Rheumatoid Arthritis Patients Treated With Tofacitinib
Abstract Number: 1801

Relationship Between MRI and Clinical Remission In Patients With Non-Radiographic Axial Spondyloarthritis After Two Years Of Adalimumab Therapy
Abstract Number: 1479

Relationship Between physicians’ Decision To Use Concomitant Glucocorticoid and Remission During Treatment With Tocilizumab In Patients With Background Of Limited Dose Of MTX
Abstract Number: 1950

Relationship Between Radiographic Joint Space Narrowing, Sonographic Cartilage Thickness and Anatomy In Rheumatoid Arthritis and Control Joints
Abstract Number: 215

Relationship Between Structural Joint Damage and Urate Deposition In Gout: A Site-By-Site Analysis Using Plain Radiography and Dual Energy Computed Tomography
Abstract Number: 778

Relationship of Meeting Physical Activity Guidelines and Quality Adjusted Life Years
Abstract Number: 2753

Relationship Of Pre-Radiographic MRI Lesions With Prevalent Frequent Knee Symptoms and Incident Persistent Knee Symptoms In Persons At Higher Risk For Knee Osteoarthritis
Abstract Number: 831

Relationships Between Clinical Outcome Measures and Gait Variables Before and After Total Hip Arthroplasty
Abstract Number: 1760

Relationships Between Driving Distance, Rheumatoid Arthritis Diagnosis, and Disease-Modifying Anti-Rheumatic Drug Receipt
Abstract Number: 2176

Relationships Between Physician and Patient Scored Clinical Outcome Measures In Pediatric Localized Scleroderma
Abstract Number: 2103

Relationships Between Self-Efficacy, Outcome Expectancy, and Outcomes In Older Adults With Osteoarthritis Of The Knee and Hypertension: Baseline Results
Abstract Number: 2788

Reliability and Responsivenss Of The Standardized Universal Pain Evaluations For Rheumatology Providers For Children and Youth (SUPER-KIDZ)
Abstract Number: 2286

Reliability and Smallest Detectable Difference Of The Patient Global Assessment, Pain and Fatigue In Rheumatoid Arthritis Patients
Abstract Number: 2868

Reliability and Validity Of Patient-Reported Joint Counts and Determinants Of Disagreement With The Physician In Recent Onset Rheumatoid Arthritis
Abstract Number: 801

Remaining Pain Is Common In Early RA Patients Treated With Methotrexate – Results From The EIRA Cohort and The Swedish Rheumatology Quality Register
Abstract Number: 1353

Remission After Twelve Month Of Treatment In The Prague Early Rheumatoid Arhritis Cohort
Abstract Number: 1977

Remission At 3 Or 6 Months and Radiographic Non-Progression At 12 Months In Methotrexate-Naïve Rheumatoid Arthritis Patients Treated With Tofacitinib Or Methotrexate: A Post-Hoc Analysis Of The ORAL Start Trial
Abstract Number: 1522

Remission In Spondyloarthritis : ASDAS and Basdai Thresholds From a Prospective Real Life Study
Abstract Number: 446

Remission Rates During Golimumab Treatment For Rheumatoid Arthritis Are Associated With Differences In Baseline Disease States Across Geographic Regions
Abstract Number: 594

Renal Biopsy Findings In Lupus Patient With Insignificant Proteinuria : Relation To Disease Activity and Clinical Manifestations
Abstract Number: 602

Repeat Biopsy In Lupus Nephritis: A Single-Center Experience
Abstract Number: 1453

Repeated High Or Low Multi-Biomarker Disease Activity (VECTRA^® DA Algorithm) Scores Associated With Radiographic Outcomes In Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors
Abstract Number: 274

Reported Macrophage Activation Syndrome In Patients With Systemic-Onset Juvenile Idiopathic Arthritis Treated With Tocilizumab
Abstract Number: 1898

Repression Of Wolf-Hischhorn Syndrome Candidate-1 (WHSC1) Contributes To The Osteoarthritis-Inducing Cartilage Loss Of Functions
Abstract Number: 989

Reproductive Counseling Program For Lupus Patients At The Systemic Lupus Erythematosus-Antiphospholipid Syndrome Center Of Excellence At Hospital For Special Surgery
Abstract Number: 2266

Research On Factors Influenced For Bone Metabolic Markers In Rheumatoid Arthritis Patients From Prospective Cohort Study
Abstract Number: 6

Researchers’ Own Experience In Managing Obstetric Complications In Pregnant Women With Antiphospholipid Syndrome
Abstract Number: 2745

Reshaping Inflammatory Macrophage Development and Functions by a Monosaccharide Analogue In Rheumatoid Arthritis
Abstract Number: 1214

Resistant Or Recurrent Acute Pericarditis: A New Therapeutic Opportunity?
Abstract Number: 521

Respiratory Compromise In Patients With Primary Sjögren Syndrome
Abstract Number: 2405

Respiratory Diseases As Risk Factors For Rheumatoid Arthritis
Abstract Number: 878

Responders To Tocilizumab Identified By Serological Measurement Of Connective Tissue Type I Collagen In Patients With Rheumatoid Arthritis
Abstract Number: 2247

Response To a Sleep Query On The Multi-Dimensional Health Assessment Questionnaire (MDHAQ) Is Related To Levels Of Disease Activity
Abstract Number: 484

Response To Biologic Disease-Modifying Anti-Rheumatic Drugs After Discontinuation Of Anti-Tumor Necrosis Factor Alpha Agents In Rheumatoid Arthritis Patients
Abstract Number: 355

Response To Etanercept With Or Without Methotrexate Combination Therapy In Patients With Psoriatic Arthritis
Abstract Number: 1141

Response To H. Pylori Treatment and Autoantibody In Chronic Thrombocytopenia
Abstract Number: 2467

Response to Tumor Necrosis Factor inhibitors In Axial Spondyloarthritis: Does Sacroiliitis Make Any Difference?
Abstract Number: 2134

Responsiveness and Predictive Ability Of The Knee Society Scale (KSS) Score
Abstract Number: 1553

Responsiveness Of Health Related Quality Of Life Questionnaires To Treatment With Anti-TNF Therapy In Psoriatic Arthritis
Abstract Number: 2275

Responsiveness Of The Outcomes Measures In Rheumatology Clinical Trials Initiative’s Preliminary Flare Questions To Detect Flares Within Patients In The Canadian Early Arthritis Cohort
Abstract Number: 306

Responsiveness To Change Of a Global Ultrasound Assessment Score In Psoriatic Arthritis Patients
Abstract Number: 2854

Restricting Back Pain and Subsequent Mobility Disability In Community-Living Older Persons
Abstract Number: 877

Results From The RATE-RA Study: A Multicenter, Single-Arm Study To Evaluate The Safety Of Administering Rituximab At a More Rapid Infusion Rate In Patients With Rheumatoid Arthritis
Abstract Number: 434

Results Of 64 Weeks Of Treatment With An Anti-IL-17 Antibody, Ixekizumab, In Patients With Rheumatoid Arthritis In a Phase 2 Study
Abstract Number: 278

Results Of a 24 Month Extension Study In Patients Who Participated In The Trial Of Early Aggressive Therapy In Polyarticular Juvenile Idiopathic Arthritis
Abstract Number: 814

Results Of a Randomised Controlled Trial Comparing Tight Control Of Early Psoriatic Arthritis (TICOPA) With Standard Care: Tight Control Improves Outcome
Abstract Number: 1943

Results of a Reliability Exercise for the Grading of Tendon Rupture in Patients With Rheumatoid Arthritis, using a Consensus-Based Ultrasound Score
Abstract Number: 2691

Results Of The Strass Trial Regarding Impact Of Progressive Spacing Of Tnf-Blocker Injections In Rheumatoid Arthritis Patients In Das28 Remission: Is There a Difference Between Drugs – Adalimumab and Etanercept – Or Their Mode Of Use – Monotherapy Or Combination?
Abstract Number: 1345

Retinal Vascular Calibre – a Novel Biomarker Of Inflammation and Treatment Response In Rheumatoid Arthritis
Abstract Number: 2782

Retreatment With Rituximab In The Rituximab In ANCA-Associated Vasculitis (RAVE) Trial
Abstract Number: 433

Retrospective Analysis Of Certolizumab Pegol Use During Pregnancy: Update Of Impact On Birth Outcomes
Abstract Number: 972

Retrospective Self-Assessment Of Pre-Course Competency: A Useful Tool For Musculoskeletal Curriculum Assessment In a Multi-Center, Interprofessional Cohort
Abstract Number: 444

Reversibility Of Pharmacodynamic Effects After Short- and Long-Term Treatment With Tofacitinib In Patients With Rheumatoid Arthritis
Abstract Number: 1387

Reversing Vascular Dysfunction In Rheumatoid Arthritis: Peroxisome Proliferator-Activated Receptor Gamma Agonist Therapy Improves Augmentation Index But Not Endothelial Function
Abstract Number: 2786

Review Of The Expert Panel Methodology In The Diagnostic and Classification Criteria For Vasculitis Study: A Pilot Study
Abstract Number: 2762

Rheumatoid and Psoriatic Arthritis Are Not Associated With Higher Risk Of Incident Diabetes Mellitus
Abstract Number: 1220

Rheumatoid Arthritis Characteristics and Fracture Risk: A Population-Based Study
Abstract Number: 2308

Rheumatoid Arthritis Flares: Inflammatory Or Avalanche?
Abstract Number: 386

Rheumatoid Arthritis Is Associated With Systemic Inflammation In Coronary Vessels
Abstract Number: 1709

Rheumatoid Arthritis Patient Cardiovascular Disease Prevention Experiences: Qualitative Analysis and Implications
Abstract Number: 181

Rheumatoid Arthritis Quality Measure Results In a Large Managed Care Population
Abstract Number: 1153

Rheumatoid Arthritis Synovial Fibroblasts Lack Tolerization Of Inflammatory Cytokines and Matrix Degrading Enzymes After Repeated LPS Stimulation
Abstract Number: 1653

Rheumatoid Arthritis Synovial IL-21+CD4+ T Cells Specifically Induce Matrix Metalloproteinase Production By Fibroblast-Like Synoviocytes
Abstract Number: 409

Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lung Inflammation Evaluated With High Resolution Computed Tomography Scan Is Correlated To Rheumatoid Arthritis Disease Activity
Abstract Number: 2407

Rheumatoid Arthritis-Related Autoantibodies In The Lung Evolve Over Time In Subjects At Elevated Risk For Future Rheumatoid Arthritis
Abstract Number: 346

Rheumatoid Arthritis, a More Severe Disease Than Psoriatic Arthritis? A Comparison Of Disease Activity In Patients With Psoriatic Arthritis and Rheumatoid Arthritis From The Swedish Early Psoriatic Arthritis Registry (SwePsA) and The Swedish Rheumatology Registry For Early RA (SRR)
Abstract Number: 1844

Rheumatoid Arthritis, Sjogren’s Syndrome and Systemic Lupus Erythematosus Patients Have a Distinct Spectrum Of Serum Anticytokine Autoantibodies
Abstract Number: 122

Rheumatologists Lack Confidence in Their Knowledge of Cannabinoid Molecules and Use in the Management of Rheumatic Disease Patients: Analysis of a Needs Assessment
Abstract Number: 2300

Rheumatologists Who Are Consistently Using An Objective Outcome Instrument Do Not “Treat To Target” In a Real World Setting
Abstract Number: 1919

Rheumatology-Ophthalmology Collaborative Uveitis Units May Improve The Diagnostic Approach Of This Pathology: Experience From a Uveitis Unit In a Secondary Spanish Hospital
Abstract Number: 1180

Rising Burden Of Gout and Poor Management Of The Disease In The United Kingdom: A Nationwide Population Study
Abstract Number: 1216

Risk Factors Associated With Fracture Occurrence Appear to Differ Between Distal Radius, Clinical Vertebral, and Hip Fractures in Japanese Patients With Rheumatoid Arthritis: A Prospective Observational Cohort Study
Abstract Number: 2048

Risk Factors For Glucocorticoids-Induced Diabetes In Patients With Rheumatic Diseases
Abstract Number: 91

Risk Factors For Incident Hyperuricemia During Mid-Adulthood In African American and White Men and Women Enrolled In The Atherosclerosis Risk In Communities Study
Abstract Number: 377

Risk Factors For Stroke In Patients With Rheumatoid Arthritis
Abstract Number: 1270

Risk Factors For The Development Of Avascular Necrosis In Pediatric Systemic Lupus Erythematosus Patients
Abstract Number: 806

Risk Of Cancer Recurrence Or New Tumors In RA Patients With Prior Malignancies Treated With Various Biologic Agents
Abstract Number: 332

Risk Of Cardiovascular Disease Among Patients With Psoriatic Arthritis Compared To Ankylosing Spondylitis (retrospective cohort study)
Abstract Number: 1720

Risk Of Cardiovascular Disease and Use Of Xanthine Oxidase Inhibitors For Gout
Abstract Number: 303

Risk Of Cardiovascular Events In Patients With Psoriatic Arthritis, Psoriasis, and Rheumatoid Arthritis: A General Population-Based Cohort Study
Abstract Number: 267

Risk Of Falls Increases With Additional Symptomatic Osteoarthritic Joints: The Johnston County Osteoarthritis Project
Abstract Number: 1039

Risk Of High-Grade Cervical Dysplasia In Women With Systemic Inflammatory Diseases
Abstract Number: 1673

Risk Of Myocardial Infarction In Patients With Giant Cell Arteritis: A Population-Based Study
Abstract Number: 2680

Risk of Subsequent Infection among Rheumatoid Arthritis Patients Using Biologics
Abstract Number: 361

Risk Of Venous Thromboembolism and Use Of Disease-Modifying Antirheumatic Drugs For Rheumatoid Arthritis
Abstract Number: 2649

Rituximab For The Treatment Of IgG4-Related Disease: A Prospective Clinical Trial
Abstract Number: 1612

Rituximab For Treatment Of Refractory Auto-Immune Hepatitis
Abstract Number: 2164

Rituximab In The Treatment Of Children With Systemic LUPUS Erythematosus: ONE Year Analysis Of 12 Patients
Abstract Number: 2783

Rituximab Versus Azathioprine For Maintenance In Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis: Follow Up At 39 Months
Abstract Number: 1485

RNA Transcripts From Peripheral Blood Mononuclear Cells As Predictors Of Clinical Responsiveness In Rheumatoid Arthritis Subjects Treated With Abatacept
Abstract Number: 1565

RNA-Sequencing Confirms Clinical Safety Of Herpes Zoster Vaccine
Abstract Number: 1489

RNA-Sequencing Identifies Novel Differentially Expressed Coding and Non-Coding Transcripts In Sjögren’s Syndrome
Abstract Number: 2194

RNA-Sequencing In Peripheral Blood Mononuclear Cells Identifies Novel Differentially Expressed Coding and Non-Coding Transcripts In Juvenile Idiopathic Arthritis
Abstract Number: 922

Role Of B Cells and/Or Autoantibodies In Pulmonary Manifestations Of Inflammatory Arthritis
Abstract Number: 532

Role Of Baseline C-Reactive Protein In Response To Infliximab Plus Naproxen Vs Naproxen Alone In Patients With Axial Spondyloarthritis
Abstract Number: 888

Role of Calcium/Calmodulin Kinase IV On Podocyte Function in Lupus Nephritis
Abstract Number: 916

Role Of CD20+ B Cells As Antigen-Presenting Cells In Arthritis
Abstract Number: 687

Role Of Class II Human Leukocyte Antigens In The Progression From Early To Definite Systemic Sclerosis
Abstract Number: 2487

Role Of IL-33 In The Development Of Premature Atherosclerosis In Psoriatic Arthritis Patients
Abstract Number: 1766

Role Of IL33 In The Inflammation Of Takayasu Arteritis
Abstract Number: 729

Role Of Innate Immunity In The Pathogenesis Of ANCA-Associated Vasculitis
Abstract Number: 2723

Role Of Interferon-Inducible RNA-Dependent Protein Kinase In The Pathogenesis Of Systemic Lupus Erythematosus
Abstract Number: 2188

Role of Interleukin-1 in Abnormal Monocyte Phenotype in Systemic Onset Juvenile Idiopathic Arthritis
Abstract Number: 2081

Role Of Muscle Persistent CD28null T Cells In Glucocorticoid Therapy Resistance In Myositis Patients
Abstract Number: 57

Role Of Procatabolic Cytokines In Dysregulation Of O-Linked N-Acetylglucosamine Modified Proteins In Human Osteoarthritic Chondrocytes
Abstract Number: 564

Role of TLR3 and dsRNA Hyper-Responsiveness in the Generation of the Lupus-Like Phenotype of New Zealand Black Congenic Mice
Abstract Number: 880

Role Of Urinary Podocyte Number and Urinary Podocalyxin Level As Biomarkers Of Glomerulonephritis In Systemic Lupus Erythematosus and ANCA-Associated Vasculitis
Abstract Number: 863

Romosozumab Administration Is Associated With Significant Improvements In Lumbar Spine and Hip Volumetric Bone Mineral Density and Content Compared With Teriparatide
Abstract Number: 119

Routine Assessment Of Patient Index Data 3 In Fibromyalgia: A Rapid and Reliable Instrument For Evaluating Disease Severity?
Abstract Number: 1527

Routine Assessment Of Patient Index Data 3 Scores Correlate Well With Bath Ankylosing Spondylitis Disease Activity Index In The Assessment Of Disease Activity and Monitoring Progression Of Ankylosing Spondylitis